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Abstract 
 
 
A genome-wide association study (GWAS) is an approach that 
involves scanning markers across complete sets of DNA, or genomes, of 
many people to indentify genetic variations associated with a particular 
disease. A GWAS uses unrelated individuals, and for the purposes of this 
study, only those who persistently stutter, to identify common genetic 
variants among these people when contrasted to the general population 
of matched ethnicity. Eighty-four affected subjects, ages 13 to 70 years, 
of northern European ancestry and 107 matched controls were 
investigated to identify replicable candidate genes that influence the risk 
of individuals to stutter. The results associated 10 significant candidate 
genes with persistent developmental stuttering. In addition, the 
pathways in which these genes function to potentially disrupt the fluent 
production of speech were investigated.  Functional significance was 
found with relevance to three functional categories pertaining to neural 
development, neural function, and behavior. Many of the genes were also 
found to be implicated in other known neurological, behavioral, and 
speech and language disorders. 
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Chapter 1 
Introduction 
 
 
 
The disorder of stuttering currently affects an estimated 50 million 
people worldwide (approximately .73% of the current population 
according to Craig, Hancock, Tran, Craig, & Peters, 2002). More 
individuals in the United States are affected with developmental 
stuttering than with AIDS, schizophrenia, Alzheimer’s disease, or 
Parkinson’s disease (Cates, 1999; Evans, 1990; Goldner, Hsu, Waraich, 
& Somers, 2002; Lilienfeld, Chan, Ehland, Godbold, Landrigan, Marsh, 
et al., 1990). Yet when compared to the research conducted on the 
etiology of these diseases, it becomes apparent that scientists know 
relatively very few details about the cause of stuttering.  
Theories developed as early as the 19th century have incorporated 
the presumption that stuttering is heritable (see review by Van Riper, 
1982). For over 80 years, scientists have noted the disorder’s 
predisposition to cluster in families. The earliest genetically oriented 
studies focused on family incidence (Gutzman, 1924; Bryngelson & 
Rutherford, 1937; West, Nelson, & Berry, 1939; Nelson, 1939). 
Throughout the following eight decades, researchers used family 
pedigrees, in the form of aggregation studies (Andrews & Harris, 1964; 
Ambrose, Yairi, & Cox, 1993; Janssen, Kloth, Kraaimaat, & Brutten, 
1996; Kidd, 1984; Yairi & Ambrose, 2002) and twin studies (Carroll, 
1965; Dworzynski, Remington, Rijsdijk, Howell & Plomin, 2007; Graf, 
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1940; Nelson, Hunter & Walter, 1945; Godai, Tatarelli, & Bonanni, 1976; 
Howie, 1976, 1981; Koch, 1966), to statistically investigate the 
hereditability of the disorder. Aggregation and twin studies could be 
conducted without the use of DNA to determine heritability. These 
studies were the first to document a high incidence of stuttering among 
first degree family members, and significantly higher concordance rates 
among monozygotic twins than among dizygotic twins.  This was 
sufficient to conclude that stuttering was “highly heritable” with little 
environmental effects (Dworzynski, et al., 2007).   
Segregation studies were then employed to match a transmission 
model to the pedigrees. Researchers needed to know how stuttering was 
passed from one generation to the next. Segregation studies, like 
aggregation and twin studies, do not require the use of actual DNA, and 
could be carried out by utilizing detailed pedigrees. The results of these 
studies remained inconclusive with several potential transmission 
models proposed (Andrews & Harris, 1964; Ambrose, Cox, & Yairi, 1997; 
Cox, 1993; Kidd, 1980, 1984; Kidd & Records, 1979; Kidd & Kidd, 1978; 
Kidd, Heimbuch, & Records, 1981; MacFarlane, Hanson, Walton & 
Mellon, 1992). The most consistent finding throughout the segregation 
studies was regarding sex influence, however, even this had some 
discrepancies (Ambrose, Cox, & Yairi, 1997).   
Technology advanced in the early 2000s allowing for scientists to 
use blood samples in an attempt to identify specific genes implicated in 
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the disorder of stuttering. Several linkage studies were carried out using 
concentrated populations of affected families found in various locations 
across the globe (Riaz, Steinberg, Ahmad, Pluzhnikov, Riazuddin, Cox, et 
al., 2005; Shugart, Mundorff, Kilshaw, Doheny, Doan, Wanyee, et al., 
2004; Suresh, Ambrose, Roe, Pluzhnikov, Wittke-Thompson,  Ng, Cook, 
et al., 2006). These studies, however, also produced inconsistent findings 
for the genes implicated, potential transmission models, and sex 
influence. 
The summation of aggregation, twin, segregation, and linkage 
studies have contributed to the basic understanding that the underlying 
cause of stuttering is genetically based. The evidence does not dispute 
the strong heritability of the disorder. It does, however, suggest that 
stuttering is complex, that the transmission model is complex, and that 
the role of sex in the disorder is also complex.  
Unfortunately, some important questions still remain, such as 
what genes are involved and how do these genes produce the phenotypic 
characteristics of developmental stuttering? Instead of using the same 
strategies of previous researchers and potentially coming up with 
additional models of transmission and theories of sex influence, this 
study aims to utilize a different type of genetic technology newly available 
for the research of complex disorders.  A genome-wide association study 
(GWAS) is an approach that involves scanning markers across complete 
sets of DNA, or genomes, of many people to indentify genetic variations 
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associated with a particular disease. This type of study does not follow 
genes through generations of family members currently or previously 
affected with the disorder. In contrast, a GWAS uses unrelated 
individuals, and for the purposes of this study, only those who 
persistently stutter, to identify common genetic variants among these 
people when contrasted to the general population of matched ethnicity. 
Moreover, the aim of this study is not only to identify replicable 
candidate genes that influence the risk of individuals to stutter, but also 
to investigate the pathways in which the genes function to disrupt the 
fluent production of speech.  
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Chapter 2 
Literature Review 
 
 
Familial Incidence  
 
 Studies investing familial incidence are designed to answer the 
most basic genetic question underlying a disorder: Does this disorder 
run in families? Bryngelson and Rutherford (1937) compared families 
containing affected probands who stutter with families containing control 
(unaffected) probands and found nearly a 3-fold increase in incidence 
among the experimental group (46% to 18%).  Bryngelson and colleagues 
followed with several similar studies which confirmed that risk for 
stuttering increases with relatedness to an affected individual.  Andrews 
and Harris (1964) and Kidd (1977) employed family studies and 
supported earlier findings that the risk of stuttering is greater within the 
families containing a person who stutters than in the general population.  
In a review of 28 familial incidence studies, Yairi, Ambrose, and Cox 
(1996), reported that a majority of those studies found familial stuttering 
in 30-60% of probands, compared to less than 10% in the families of 
control probands. In their own study, Ambrose, Yairi, and Cox (1993) 
found 28% of children who stutter to have a parent who also stutters, 
43% have an affected member in their immediate family (siblings and/or 
parents), and 71% to have stuttering in their immediate family or in their 
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extended family.   
 
Family Aggregation Studies 
 
 Aggregation studies focus on distribution patterns of a disorder 
throughout familial pedigrees. They meticulously take into account 
relatedness of family members and family size. Specifically, they not only 
calculate the number of affected members within a family (as in familial 
incidence studies), they also focus on the relationship any given 
affected/non-affected member has to an affected proband. Andrews and 
Harris (1964) were the first to perform an aggregation study on 
stuttering. They looked at male and female affected probands and 
calculated the incidence of stuttering found among their fathers, 
mothers, brothers, and sisters. Two hundred and fifty six pedigrees from 
probands age 2 years to adult were surveyed. Percentages of first-degree 
affected relatives of male and female probands are shown in Table 2.1. 
 
Table 2.1 Percentages of Affected 1st degree Relatives reported by 
Andrews and Harris (1964) 
Sex of Proband Fathers Mothers Brothers Sisters 
Male  17.6 6.4 18.7 6.1 
Female  25.7 8.3 29.9 19.4 
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Interestingly, the study reported a significantly higher incidence of 
stuttering among the male relatives of either sex proband (with the 
exception of affected sisters of female probands, which was comparable 
to male relatives). However, the greatest risk of stuttering occurred for 
relatives of female probands. The average non-sex specific risk of any 
first-degree relative of a female proband to be affected was reported at 
20.2%1. The risk of being an affected male relative of an affected female 
was even higher as observed in very high percentages of affected fathers 
and brothers of females who stutter. In contrast, male probands had a 
non-sex specific risk of 12.2% for having an affected first-degree relative. 
This is nearly half the reported risk for female probands. Female relatives 
of males who stutter were at the lowest risk for stuttering. 
Very similar results were reported by Kidd (1984) in a replication 
study of Andrews and Harris’ (1964) study. Information was gathered 
from 600 complete pedigrees of affected adult probands. Familial 
incidence and aggregation information was compiled for these families 
(see Table 2.2).  
 
 
 
 
 
                                                 
1 This number is calculated by averaging all first-degree relative stuttering risk percentages of female 
probands.  Male proband non-sex specific stuttering risk was also calculated accordingly. 
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Table 2.2. Percentages of Affected 1st degree Relatives reported by Kidd 
(1984) 
Sex of Proband Fathers Mothers Brothers Sisters 
Male  18.4 4.4 19.4 4.1 
Female  20.4 11.7 23.1 12.8 
 
 The percentages of incidence for affected first-degree relatives were 
nearly identical to Andrews and Harris (1964). The study confirmed the 
earlier presented findings that relatives of females were at a much higher 
risk of stuttering than the relatives of male probands.  
 Ambrose, Yairi, and Cox (1993), investigated the frequency of first 
degree affected relatives of 69 affected pre-school age probands (ages 2-6 
years). Aggregation for this study is reported in Table 2.3. 
 
Table 2.3 Percentages of Affected 1st degree Relatives reported by 
Ambrose, Yairi and Cox (1993) 
Sex of Proband Fathers Mothers Brothers Sisters 
Male  31.3 4.2 24.3 10.7 
Female  4.8 4.8 33.3 40.0 
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Numbers observed in this study indicate a greater risk for affected 
relatives of male probands than previously reported by Andrews and 
Harris (1964), and Kidd (1984). Non-sex specific risk rates were 17.63% 
for relatives of male probands, and 20.7% for relatives of female 
probands. The difference in sex ratio findings were not statistically 
significant. Unlike the two previous studies, Ambrose et al. (1993) used 
child-age probands instead of adults. They stated that their sample 
“provided a considerably more accurate representation of the affected 
population” as it included “children who recovered naturally, who would 
have been unidentified or excluded from other studies” (Yairi & Ambrose, 
2002, p. 12).    
Janssen, Kloth, Kraaimaat, and Brutten (1996) performed a 
replication study of Ambrose et al. (1993), with adult probands that 
specifically aimed at investigating the relationship between the gender of 
stuttering probands and the incidence of stuttering among their relatives. 
Detailed pedigrees from 106 affected adults were analyzed and the 
results are reported in Table 2.4 More affected brothers and fathers were 
reported for both male and female probands, a trend that is also evident 
in previous studies. While percentages of sisters of affected probands 
mirror those reported in Andrews and Harris (1964), the non-sex specific 
risk rates for relatives of female probands was nearly equal to the rate for 
relatives of male probands (16% and 15.1% respectively).  The 
researchers concluded that they were in agreement with Ambrose et al. 
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(1993). Their evidence did not support the increased likelihood for 
relatives of female probands to be at a higher risk for stuttering than 
those of male probands.  
 
Table 2.4 Percentages of Affected 1st degree Relatives reported by 
Janssen, Kloth, Kraaimaat, and Brutten (1996) 
Sex of Proband Fathers Mothers Brothers Sisters 
Male  22.1 5.2 23.3 9.7 
Female  24.1 0 20.3 19.6 
 
 
Yairi and Ambrose (2002) found the brothers of female probands to 
be at a greater risk for stuttering than reported by the four previous 
aggregation studies (see Table 2.5). This finding, however, did not 
significantly influence the overall non-sex specific risk ratios for first-
degree relatives of either proband to deviate from previously reported 
trends. Risk for relatives of males was calculated to be 18.6%, and 21.4% 
for females; demonstrating less than a 3% difference between the two 
affected genders. 
 
 
 
 
 
 
10
 
 
 
Table 2.5 Percentages of Affected 1st degree Relatives reported by Yairi 
and Ambrose (2002) 
Sex of Proband Fathers Mothers Brothers Sisters 
Male  25.7 5.7 28.6 14.7 
Female  15.2 6.1 50.0 14.3 
 
In summary, the aggregation studies demonstrate a markedly high 
incidence of stuttering among first degree family members, with a trend 
toward affected male relatives of either male or female proband to be at a 
slightly higher risk for stuttering than female relatives (average father 
risk 20.5%, brother risk 27.1%, mother risk 5.7%, and sister risk 
15.14%). In contrast, if one isolates the most recent studies from the 
entire body of literature on this topic, it is evident that they report the 
non-sex specific risk for stuttering to be approximately equal for relatives 
of male and female probands.    
 
Twin Studies  
 
 While familial incidence and family aggregation studies appear to 
be quite compelling in supporting the argument for stuttering 
heritability, some argue that the evidence could suggest otherwise. For 
example, religion, dialects, attitudes and beliefs also run in families 
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without having a genetic etiology. In search of answers, scientists turned 
to twin studies. 
 Twin studies have been employed for the last 65 years to 
investigate the heritability of stuttering and potential environmental 
influences. Concordance of stuttering in twin pairs has been calculated 
by several researchers (Carroll, 1965; Dworzynski, Remington, Rijsdijk, 
Howell & Plomin, 2007; Graf, 1940; Nelson, Hunter & Walter, 1945; 
Godai, Tatarelli, & Bonanni, 1976; Howie, 1976, 1981; Koch, 1966) in an 
attempt to partition genetic variance of stuttering from environmental 
effects.  
Andrews, Morris-Yates, Howie, and Martin (1991) questioned 2438 
twin pairs about their stuttering history. The twins were listed in an 
Australian twin registry and contacted first by mail then by telephone 
interview. They reported a 71% estimate of hereditability for additive 
genetic variance (genetic alleles at two or more gene loci producing 
combined effects equal to the sum of their individual effects).  Felsenfeld, 
Kirk, Zhu, Statham, Neale, and Martin (2000), found nearly identical 
results to those of Andrews and colleagues (1991), they also used 
telephone interviews to diagnose 457 individuals who stutter from an 
Australian twin registry.  Using a screening tool, they found 
approximately 70% of genetic variance in stuttering to be due to additive 
genetic effects, and the remaining 30% due to non-shared environmental 
effects.   
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Sheehan and Costley (1977) in a review of twin literature from 
1937-1976, reported concordance rates far below those reported in more 
recent studies (see Table 2.6 below). Godai, Tatarelli, and Bonanni (1976) 
investigated 63 twin pairs (22 Monozygotic and 41 Dizygotic), with one or 
both members affected. The study’s findings showed a high concordance 
of stuttering in monozygotes 83% and only 10.5% in dizygotes.  Howie 
(1981) used interviews to investigate same sex twins, and found 
concordance to be similar to Godai et al. (1976), with concordance rates 
of 63% in monozygotes and 19% in dizygotes. These findings suggest very 
strong evidence for genetic heritability in stuttering. Despite the lack of 
perfect concordance of stuttering among monozygotic twins, the stronger 
correlation is notably higher than that for fraternal (dizygomatic) twins. 
In light of this, Cox (1988) emphasized that the absence of perfect 
concordance in identical twins indicates that other factors beyond simple 
genetic transmission must play a role in the etiology of stuttering. These 
other factors may be present environmentally. A shared environment, 
however, may not be the source. Dworzynski, et al. (2007) found very 
little to support the involvement of shared environment effects in 
heritability. Their study assessed concordance rates, heritability, and age 
related predictability of persistence or recovery of stuttering. Their 
findings supported significantly higher concordance rates among 
monozygotes than among dizygotic twins.  In agreement with previous 
studies, their findings support the assumption that stuttering is “highly 
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heritable” with very little shared environment effects. 
 
Table 2.6 A Summary of Twin Studies Reporting Concordance Rates of 
Stuttering 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investigator Year Subjects Findings MZ DZ 
Berry 1937, 
1938 
250 twin pairs Stuttering occurs 
more frequently in 
twins than in non-
twin population 
na na 
Nelson, Hunter 
& Walter 
1945 200 twin pairs Concordance Rates 14% 23% 
Graf 1955 552 twin pairs Concordance Rates 11% 22% 
Carroll 1965 1958 cws, both 
twin and non-
twin 
Stuttering occurs at 
equal incidence 
rates between 
groups 
na na 
Koch 1966 90 twin pairs Concordance equal 
between dizygotes 
and monozygotes  
  
Howie 1976 42 twin pairs Concordance Rates 58-
63% 
13-
19% 
Godai, Tatarelli, 
& Bonanni 
1976 63 twin pairs, 
one or both 
affected 
Concordance Rates 83% 10.5
% 
Howie 1981 30 twin pairs Concordance Rates 63% 19% 
Andrews, 
Morris-Yates, 
Howie, & Martin 
1991 135 twin pairs 
with one or 
both affected 
Concordance Rates 20% 5.4
% 
Felsenfeld, Kirk, 
Zhu, Statham, 
Neale, & Martin 
2000 457 affected 
twins or co-
twins 
Concordance Rates 
Screening Method 
Interview Method 
 
17% 
45% 
 
6% 
15% 
Dworzynski 
Remington, 
Rijsdijk, Howell 
& Plomin 
2007 1,025 twin 
children 
affected 
11,867 twin 
control 
unaffected 
Concordance Rates 
Age 3 
Age 4 
Age 7 
 
26% 
32% 
29% 
 
9% 
12% 
3% 
Portions of this table are adapted from Sheehan & Costley, 1977, p.55. 
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Genetic Models of Stuttering  
Segregation Analysis 
 
Segregation analysis is applied to pedigrees of interest in an 
attempt to match genetic models to the observed patterns of 
transmission of a trait within families. Complex segregation analysis 
uses a statistical model to dissect major gene effects in diseases where 
abnormal penetrance, mutation carriers, and non-Mendelian disease 
transmission is probable (Bonney, Lathrop, & Lalouel, 1988).  
Segregation patterns studied within pedigrees of stuttering probands 
have reinforced the need for complex analysis to investigate the 
transmission of this disorder.  Results from aggregation studies, paired 
with a male-favored sex ratio of incidence and prevalence, has long 
fueled a debate among scientists regarding the influence of gender in 
segregation models.  
 
Sex-specific Heritability  
 
 Initially, childhood incidence of stuttering is observed to have a 
sex-effect of 2:1 or even smaller male-to-female ratio (Mansson, 2000; 
Yairi, 1983). As the disorder progresses into adulthood, more females 
reportedly recover from stuttering and the ratio becomes closer to 4:1 or 
5:1 (Bloodstein, 1995; Yairi & Ambrose, 1992, 1999, 2005; Yairi, 
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Ambrose, & Cox, 1996).  Ambrose et al. (1993) specifically reported that 
more girls recover from stuttering than boys.  These observations have 
led researchers to believe to that there may be sex-specific genes 
responsible for stuttering and potentially for natural recovery.   
 The first segregation analysis was attempted by Andrews and 
Harris (1964) in an effort to identify genetic transmission of stuttering 
among their 256 detailed pedigrees. Their definitive findings suggested a 
model with sex-modified expression, but the specifics appeared complex 
and unclear.  It took nearly 15 years for the next segregation analysis in 
stuttering to be attempted. In agreement with Andrews and Harris 
(1964), Kenneth Kidd first proposed a sex-modified trait hypothesis for 
stuttering transmission in 1978. The initial study investigated 51 
affected probands and their first degree relatives. The experiment was 
performed at Yale University and was followed by larger subsequent 
studies known as the Yale Studies, all supporting the sex-modified 
theory (Kidd, 1980, 1984; Kidd, Heimbuch, & Records, 1981). Kidd and 
Records (1979) defined stuttering as a complex trait that could be 
transferred by a number of sex-modified multifactorial models.  
Kidd (1981) used 386 probands and their first degree relatives to 
demonstrate vertical transmission of stuttering in families and support 
the previous hypothesis of susceptibility to sex-modified expression. The 
pedigrees used in this study specifically suggested a sex-modified 
polygenic threshold model (this was a minor adjustment to the previously 
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suggested single-gene or polygenic transmission model (Kidd (1980)). 
Diseases or traits for which the genetic component is attributable to 
many genes acting additively are referred to as polygenic (e.g fingerprint 
ridges (Mendenhall, Mertens, & Hendrix, 1989)). These genes may be on 
the same chromosome or on several different chromosomes. In an 
additive model, the contribution of the alleles are additive. For example, 
consider an additive gene affecting height in which the A allele has no 
effect on height, but the a allele increases height by 1 cm. Individuals 
with the AA genotype have no effect of genotype at the A gene on height 
while heterozygous individuals (Aa) have, on average, a 1 cm increased 
height.  An individual homozygous for a (aa) would have according the 
additive effect, on average, a 2 cm increased height.  In a polygenic model 
many genes contribute to a phenotype in this additive way. The effects 
are simply additive across genes as well.  If a second gene, B also affects 
height, with the B allele having no affect on average height and the b 
allele increasing height by 2 cm, someone who has the AaBb genotype 
would be 3 cm taller than the average. 
Some phenotypes are multifactorial, which means they are not 
only polygenic but also influenced by many non-genetic factors, such as 
the pre- and post-natal environment (e.g height (Karlin, Williams, 
Jensen, & Farquhar, 1981) and skin color). Some traits are influenced by 
the sex of the individual; this is often documented as dimorphic traits. 
Some dimorphic multifactorial traits, such as cleft lip/cleft palate 
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(Christensen and Mitchell, 1996; Farrall & Holder, 1992; Mitchell & 
Risch, 1992), are more common in males than females (Fogh-Andersen, 
1942) and exhibit a threshold effect (Farrall & Holder, 1992). This 
supports the hypothesis that there must be a certain number of additive 
genes for the trait to express itself phenotypically. In cleft lip/cleft palate, 
females exhibit a higher threshold and require more genes for 
expression. This results in affected females having higher incidences of 
affected offspring than observed in the offspring of affected males 
(Marazita, Goldstein, Smalley, & Spence, 1986). In disorders such as cleft 
lip/cleft palate and perhaps stuttering, all people are assumed to carry 
some of the responsible genes. It is the combined effect of both parents’ 
contributing genes that will either exceed the threshold for expression or 
result in a very mild disorder to falling within normal limits.  
In 1984, Cox, Kramer, and Kidd, proposed a new hypothesis of 
multifactorial-polygenic transmission with a major loci or locus.  A 
complex segregation model was used to analyze stuttering transmission 
and the possibility of a single Mendelian locus as a potential explanation 
was ruled out. This study built upon Kidd and colleagues’ previous ideas 
and reiterated the role of sex-modified transmission.  
MacFarlane, Hanson, Walton and Mellon (1991) investigated five 
generations of a Utah family demonstrating above average incidence of 
stuttering rates among its members. The investigators selected a 
subgroup (two generations) consisting of 38 affected probands and 231 
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unaffected relatives. Their findings supported Kidd’s (1981) sex-modified 
polygenic threshold model. 
Ambrose, Cox, and Yairi (1997) did not support the above findings 
with their segregation analysis of 66 pedigrees and rather suggested a 
major locus in combination with multifactorial polygenic influences. 
Although the study did not include a sex factor in its transmission 
model, the investigators did report significant differences in recovery 
rates among males and females.  In an earlier study, Ambrose, Yairi, and 
Cox (1993) used segregation analysis on 69 affected children (ages 2;1 to 
6;3) to test three models of genetic transmission. These were MFP 
(Multifactorial /polygenic model), SML (single major locus model), and 
MM (mixed model of both MFP and SML).   They found statistically 
significant evidence for a Mendelian major locus component to stuttering 
transmission. They reported that while their evidence supported the role 
of a major gene, it remained irrefutable that multiple additional genes 
were also involved.  
 Viswanath, Lee, and Chakraborty (2004) also disputed the 
evidence that a polygenic threshold model alone could result in the 
observed familial aggregation without a major gene. They applied 
complex segregation analysis to 47 pedigrees and found transmission of 
stuttering in the sample to be consistent with an autosomal diallelic 
major locus model influenced by the two covariates of sex and affection 
status of the parents.   
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Drayna, Kilshaw, and Kelly (1999), purposed that those who 
stutter belong to one of two groups: a group with a genetic etiology, and a 
group without genetic etiology (sporadic). Drayna et al. (1999) used the 
data from 137 males and 87 females of the general public representing 
all racial groups and demographics. They found that nearly half of the 
participants had a family history for stuttering. This study supported the 
findings of Yairi, Ambrose, and Cox (1996) and had a significantly higher 
number of females who reported a family history of stuttering than 
males.  The sporadic cases were theorized to affect more males than 
females, in contrast to the genetic cases which are presumed to be 
equally represented in both males and females.  
All of the above studies, except one (Ambrose et al., 1997), 
suggested theories of sex-modified expression in stuttering transmission. 
Studies performed by Ambrose and colleagues, however, did not deny sex 
as a key feature, as demonstrated by reported sex differences in 
incidence rates, they merely did not find a sex-modified component in 
their sample. Gender differences in people who stutter are of interest 
when considering the disparity in natural recovery rates of males and 
females. Much of the research done in genetics has targeted some aspect 
of sex-modification in traits or transmission in an attempt to explain 
higher male prevalence ratios.  This component of many studies, while 
interesting, has not been irrefutably proven, nor its’ role critical to the 
discovery of replicatable genes responsible for stuttering. 
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In summary, researchers have agreed that simple single-gene fully 
penetrant transmission models of inheritance of stuttering, such as 
autosomal dominant, recessive, and x-chromosome-linked transmission 
models are unlikely (Kidd et al., 1981; Kidd, 1984; MacFarlane et al., 
1991; Cox, 1993; Ambrose et al., 1993; Viswanath, Rosenfield, 
Alexander, et al., 2000). Segregation studies investigating stuttering have 
not conclusively explained transmission of this disorder, but they have 
provided a starting point for further genetic investigation, namely by 
means of linkage analysis. The “role of segregation analysis is to provide 
a specific genetic model for subsequent linkage analysis (Viswanath et 
al., 2004, p.410).”  
 
Biological Genetics 
Identification of Specific Genes 
 
 Two main approaches are employed to identify gene-disorder or 
gene-trait relationships: association and linkage.  Both strategies use 
genetic markers to analyze variations within either families (using 
linkage) or entire populations (using association).  Genetic markers are 
stretches of DNA that exhibit variations between individuals or 
populations (McGuffin, Owen, & Gottesman, 2002).  
Markers typically fall into two categories: polymorphisms with two 
alleles and those that are multi-allelic.  The word polymorphism simply 
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indicates that there is more than one type of DNA sequence at the site, 
and each DNA sequence type at a site is called an allele.  Most two-allele 
polymorphisms are caused by a mutation exchanging one base within a 
DNA sequence for another: e.g. a DNA sequence of AATCG may become 
AAGCG, in this example the 3rd base position is polymorphic, with two 
alleles, a T allele and a G allele. A smaller number of two-allele 
polymorphisms are actually segments of DNA in which one or more bases 
have been deleted.  Thus, a DNA sequence may exist as AATCG and AAG, 
in which the middle TC has been deleted. The second type of marker 
(multi-allelic) occurs when several different versions of the genetic 
marker are found within the same population, typically resulting from a 
portion of the DNA (between 2 and 100 base-pairs long) being repeated in 
short sequence repeats (SSRs) or longer variable number tandem repeat 
markers (VNTRs)(Eley & Craig, 2005).  Most polymorphisms, whether 
two-allele or multi-allelic have no consequence to the organism, but may 
be used in genetic studies as “markers” to help us localize the small 
number of polymorphisms that actually affect disease to the correct 
region of the chromosome on which these disease alleles reside.   
 
Linkage Analysis 
 
Linkage analysis traces the inheritance pattern of genes as they 
are passed from generation to generation. Although the analysis of 
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pedigrees in a complex segregation analysis can provide information on 
the genetic model underlying a disease or trait, geneticists and clinicians 
hoping to improve diagnosis and treatments for patients are more 
interested in knowing precisely which genes have polymorphisms that 
might affect risk of disease.  Linkage analysis is one way to determine the 
genetic location of a trait gene or disease gene. The closer alleles lie along 
a chromosome the higher their chance of being inherited together. In 
other words, where they exist regionally and in relation to each other on 
a single chromosome influences their chance of being linked during 
cellular reproduction.  The goal of linkage analysis is to identify a piece of 
DNA in a known chromosomal location that is inherited by all affected 
family members of the disorder being investigated, and is not inherited 
by any of the unaffected family members. A co-inherited (or co-segregate) 
polymorphism is a piece of DNA that can be statistically associated with 
the disease phenotype within a family. Since linkage analysis uses 
markers or polymorphisms to define relatively large segments of genetic 
material likely to contain a polymorphism that causes or contributes to 
disease, further analysis is needed once a region has been implicated to 
identify the relevant gene polymorphism.  
Several studies have used linkage analysis to investigate families 
with high numbers of stuttering members. They looked for highly 
variable genetic markers.  Riaz et al., (2005) looked at 44 highly inbred 
families from Lahore, Pakistan.  Using microsatellites, they genotyped 
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144 stuttering (affected) and 55 non-stuttering (unaffected) individuals.  
Evidence of linkage was found on chromosomes 1, 5, 7, and 12.  
Additional analysis was performed on chromosome 12 (using a 5-cM level 
of resolution).  They suggested that an unspecified locus on chromosome 
12q (long arm) “may contain a gene with a large effect in this sample” (p. 
647). This study included highly inbred individuals, suggesting that the 
findings may be linked to a common mutational origin for stuttering 
specific to these families. Hence, they may have different genetic 
components underlying stuttering than those present in genetically 
diverse populations. Therefore, the mode of inheritance for disease-
associated haplotypes is difficult to clearly identify with confidence.  
Shugart et al. (2004) performed a linkage analysis on 68 families 
from the general population of North America and Europe. Investigating 
392 markers across the genome, statistical support was found on 
chromosome 18. Fine mapping was employed by examining 18 additional 
markers on Chromosome 18. Several candidate regions, including 
proximal regions of 18q, were identified with low to moderate levels of 
statistical significance.  
Suresh and colleagues (2006) did a linkage analysis of 100 
European-descent probands.  They found Chromosome 9 to be 
moderately linked to a diagnosis of “ever stuttered.” A somewhat weaker 
finding was on chromosome 15 for persistent individuals. The only 
genome-wide significant findings was for sex-specific linkage on 
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chromosome 7 for males and chromosome 21 for females.  The study 
supported sex effects as genetic components to stuttering. 
 
Table 2.7 Summary of Linkage Studies 
Study Year 
Most 
Important 
Chromosome 
Other 
Chromosomes Population 
Shugart 
et al. 
2004 18 1, 2, 10, and 
13  
Compared one 
model family with 
6 affected to 68 
families in North 
America and 
England 
Riaz et 
al. 
2005 12 1, 5, 7, 12 47 highly inbred 
Pakistani families 
Suresh 
et al. 
2006 9, 15, and 
conditionally 
2 
Male specific 
on 7, Female 
specific on 21 
100 families of 
European origin, 
USA, Sweden, & 
Israel 
Wittke-
Thomps
on et al. 
2007 13 1, 3, 5, 9, 13, 
15 
One 232 person 
family with 48 
‘affected’ 
individuals 
(founder 
population 
Hutterites) 
 
Kang, Riazuddin, Mundorff, Krasnewich, Friedman, Mullikin, and 
Drayna (2010) re-investigated a region on chromosome 12, using the 
same initial population used in Riaz et al., 2005 (highly inbred Pakistani 
families n=47). The study included an additional 77 unrelated affected 
Pakistani subjects and 270 affected North American and British subjects. 
Using linkage analysis, they found a mutation in the GNPTAB gene in a 
large Pakistani family (PKST72). Drayna and colleagues were able to 
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identify this gene in five other affected individuals from the Pakistani 
population, and in one North American person of Asian-Indian ancestry.  
Three mutations of an additional gene on chromosome 12 (NAGPA gene) 
were observed in 6 affected North American-British subjects but not in 
any member of the Pakistani population. GNPTAB and NAGPA govern 
lysosomal metabolism and are largely associated with cardiovascular, 
bone, and connective tissues. 
Major limitations of linkage studies exist as a result of the 
relatively low statistical power for samples of complex disorders. The 
power is drastically influenced by multiple genes and the often hundreds 
of the chromosomal regions shared among family members not related to 
the disorder of interest. It can be difficult to narrow the linkage signal in 
these samples sufficiently to identify a causative gene (Pearson & 
Manolio, 2008).  For non-Mendelian complex disorders, such as 
atherosclerosis and asthma and presumably stuttering, a different type 
of genetic analysis would provide a valuable advantage over family-based 
linkage studies.  
 
Genome-Wide Association  
 
 A genome-wide association study (GWAS) is an approach that 
involves scanning markers across complete sets of DNA, or genomes, of 
many unrelated people to find genetic variations associated with a 
 
 
26
 
 
particular disease. It is based on the assumption that heritable risk for a 
common disease is mostly attributable to a relatively small number of 
genetic variants (Hunter, Altshuler, & Radar, 2008; Pearson & Manolio, 
2008). Association mapping studies are designed to identify particular 
alleles (genetic variants) that are found more frequently in affected 
individuals than in unaffected individuals. Such alleles either directly 
affect risk of disease or are in linkage disequilibrium (when alleles are 
found more or less frequently than expected by random combinations) 
and physically very close to alleles that directly affect risk of disease. 
This systematic study of genetic variations is expected to lead to the 
localization of causal genes (Hunter et al., 2008) without the need for 
prior hypothesis regarding genetic associations with the disorder of 
interest (Hirschhorn & Daly, 2005). 
A GWAS allows for very large numbers (906,600) of polymorphisms 
across the entire human genome to be analyzed for variants (Li, Li, & 
Guan, 2008; Wang & Wang, 2009). The Affymetrix SNP (single nucleotide 
polymorphism) array 6.0 can investigate 1.8 million markers on a single 
microarray (Affymetrix Inc., Santa Clara, CA, USA). This type of 
microarray contains a large, high-quality platform that can be used to 
genotype an entire sample population (Wang & Wang, 2009). Single 
nucleotide polymorphisms are the most ideal marker for association 
studies because of their abundance. Roughly 12 million human SNPs 
have been uniquely assigned a reference number in the National Center 
 
 
27
 
 
for Biotechnology Information’s SNP database (Wheeler, Barrett, Benson, 
Bryant, Canese, et al., 2008).   
To date, there have been no genome-wide association studies of 
stuttering. Therefore, models for this type of study must come from 
research in other speech and language disorders. Specific Language 
Impairment (SLI) has been intensively studied since the identification of 
FOXP2.  
 
FOXP2   
 
 The discovery of FOXP2 located on chromosome 7, by Hurst and 
colleagues (1990), has been pivotal in our identification and 
understanding of genes responsible for speech and language. The British 
family (KE family) from which a mutation in FOXP2 was identified, 
exhibited an autosomal dominant transmission (Mendelian model) of 
Specific Language Impairment. Affected probands in the KE family 
exhibited oral-motor speech dyspraxia, low nonverbal IQ, and impaired 
expressive and receptive language abilities that were traced through 
three generations (Vargha-Khadem, Watkins, Alcock, Fletcher, & 
Passingham, 1995). Since its initial discovery, many studies have further 
investigated FOXP2 (7q31) and FOXP2-regulated genes looking for an in-
depth understanding of how this gene works and manifests its proteins 
as Specific Language Impairment (SLI)(Lai, Fisher, Hurst, Vargha-
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Khadem, & Monaco, 2001; Spiteri, Konopka, Coppola, Bomar, Oldham, 
Ou, et al., 2007; Vernes, Spiteri, Nicod, Groszer, Taylor, Davies, et al. 
2007; Whitehouse, Barry, & Bishop, 2008). These related studies have 
uncovered overlap genes associated with autism, schizophrenia, Silver-
Russell Syndrome, and Alzheimer’s disease (Feuk, Carson, & Scherer, 
2006; Whitehouse, Barry, & Bishop, 2008).  While mutations in FOXP2 
are found to be rare outside of the KE family (MacDermot, Bonora, 
Sykes, Coupe, Lai, Vernes, et al. 2005), the discovery itself has provided 
scientists with a springboard to facilitate neurogenetic investigations of 
spoken language. Fisher and Scharff (2009) discuss the broader 
relevance of downstream effects of FOXP2, such as one found in a 
genetic screening that uncovered CNTNAP2 (contactin-associated 
protein-like 2), which binds to FOXP2. CNTNAP2 is a neurexin 
transmembrane protein that functions in neuron-glia interactions and is 
involved in cell adhesion and neuronal recognition (Inda, DeFelipe, & 
Munoz, 2006; Vernes, Newbury, Abrahams, Winchester, Nicod, Groszer, 
et al. 2008). CNTNAP2 has been found to be involved in the development 
of the cerebral cortex (Lai, et al., 2003), specifically cortical layers (Vernes 
et al., 2008), and frontal grey matter development (Abrahams, Tentler, 
Perederiy, Oldham, Coppola, & Geschwind, 2007), an area critical to 
speech and language. Interestingly, mutations of CNTNAP2 were found in 
a family exhibiting developmental malformations of their cerebral cortex, 
epilepsy, language disorders, and autistic characteristics (Strauss, 
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Puffenberger, Huentelman, Gottlieb, Dobrin, Parod, et al, 2006).   
 Whereas this discovery does not directly affect our understanding 
of stuttering, it does provide an encouraging model. The discovery of 
FOXP2 started with a very small study; 16 affected probands and 15 
unaffected family members. Since its initial implications within the KE 
family, subsequent studies have led researchers to more and more 
information that is slowly piecing together our understanding of 
neurogenic contribution/involvement in language disorders.  
 
Behavioral Genetics  
The Environment 
 
DNA is both inherited and environmentally responsive (Robinson, 
2004a). “What genes actually do in the brain reflects the interaction 
between hereditary and environmental information” (Robinson, 2004b).  
Many phenotypes relevant to aspects of human behavioral development 
are influenced not only by the environment, but also by multiple genes, 
and thus are referred to as ‘complex’.  Stuttering has been identified by 
several researchers as a complex trait (Cox, Kramer, & Kidd, 1984; Kidd, 
1979; Riaz et al., 2005)  
  Genetic variants that affect complex traits are neither necessary 
nor sufficient enough to cause a particular disorder on their own. 
Independently, each variant has a small effect size and requires that 
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many be present for an individual to be classified as affected with the 
disorder.  When these genetic traits can be measured quantitatively, the 
genes with variation contributing to them are known as quantitative trait 
loci (QTL)(Eley & Craig, 2005).   Since genetic studies for complex 
disorders must identify multiple genes responsible for the etiology, 
methods for identifying QTLs are very different than identifying genes for 
disorders with a single contributing gene (ie. Huntington ’s disease).   
Quantitative genetic strategies facilitate measurement of genetic 
variation responsible for complex traits. “The strength of quantitative 
genetics is that it can examine the net effects of genetic and 
environmental influences on complex traits regardless of how many 
genes or environmental factors affect the traits and without knowing 
what those genes or environmental factors are” (Harlaar, Butcher, 
Meaburn, Sham, Craig, & Plomin, 2005, p. 1097).  
 Taking into consideration the influential role the environment 
undoubtedly plays in the severity of stuttering, it is reasonable to 
assume that the environment may also play an interactive role with the 
development and genetics of stuttering. Continuing in the pursuit of 
definitive answers, quantitative genetic strategies are scientifically logical 
to pursue.  
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Theories, Rationale, and Hypothesis 
Theories    
 
People differ greatly in all aspects of what is casually known as 
speech fluency. A continuum of abilities and coordination exists not only 
in fluent speakers, but in those classified with the disorder of stuttering 
as well.2 Wide variability is often observed among affected individuals.  
This variability manifests itself in frequency and duration of stutters, 
type of stutters predominantly displayed, tension, secondaries, and age 
at onset (among other characteristics), as well as trends toward 
persistency or recovery.  There is no wonder why decades of work 
dedicated to the understanding of etiological factors, resulting in the 
manifestation of such a disorder, would also produce results as varied 
and complex as the disorder itself.  “.. so far, not a single cause of 
developmental stuttering has been unequivocally identified” (Yairi & 
Ambrose, 2002, p. 10). “A number of epidemiological findings are 
consistent with the notion of strong genetic influences in the etiology of 
stuttering, but concerted efforts to find specific genes that account for 
the susceptibility, and heredity patterns, are still in their infancy” 
(Dworzynski et al., 2007, p. 169 ). An undeniable abundance of literature 
has pointed to genetic underpinnings, yet the specifics remain elusive.  
                                                 
2  Unlike Bloodstein’s continuity hypothesis (1970), which suggests that stuttering 
moments and moments of normal disfluency lie on a continuum, this reference is to two 
distinct groups, those who do, and those who do not stutter. 
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Three potential theories may account for the evident variability: 
 
1. Final Common Pathway Theory 
 
 Mellon, Umar, and Hanson (1993) theorize that perhaps dozens of 
gene variants lead to the phenotype of stuttering. They refer to this idea 
as the “final common pathway.” They propose that heterogeneity is 
paired with factors that reduce the penetrance of the phenotype through 
chaotic influences during development. Mellon and Clark (1990) use 
evidence of developmental plasticity to support their ideas.  
Neurological studies published after the 1990s have built on the 
framework of developmental plasticity specifically under the realm of 
neuroplasticity.  The evidence for neuroplasticity demonstrates the 
brain’s ability to repair, reorganize, recover and build from 
environmentally induced changes or demands occurring post natum. 
Examples of trauma, learning, and pain rank among widely researched 
evidence for this phenomenon. Functional differences in people who 
stutter have been observed with fMRI, PET, and EGG studies (Ingham, 
Fox, Ingham, Zamarripa, Martin, & Jerabek, 1996; Watkins, Smith, 
Davis, & Howell, 2007). It remains unclear if these differences precede 
the onset of the disorder, or are themselves, examples of neuroplastic 
reorganization resulting from the experience of stuttering.    
Learning induced neuroplasticity has been proven to be reflected 
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even at the structural level. One study taught 24 adults to juggle, and 
compared them with age-gender-matched controls. Brain scans were 
performed prior to 3 months of juggling training for the experimental 
group. The researchers not only found functional changes in the brain, 
but also structural changes in the brain. They rescanned the groups after 
three months of no juggling, and found the structures had returned to 
near baseline measurements (Draganski, Gaser, Busch, Schuierer, 
Bogdahn & May, 2004). This study demonstrates just how anatomically 
flexible the human brain is even within a relatively short period of time. 
This phenomenon may help explain structural neuroanatomical 
differences observed in adults who stutter (Foundas, Bollich, Corey, 
Hurley, & Heilman, 2001; Sommer, Koch, Paulus, Weiller, & Büchel, 
2002) and in children who stutter (Chang, Erickson, Ambrose, 
Hasegawa-Johnson, & Ludlow, 2007). One of the structural differences 
found among affected individuals is in the number and shape of cortical 
gyri. “Considering that gyrification is a complex developmental 
procedure, these findings indicate a developmental disorder (Büchel & 
Sommer, 2004, p. 162).”  The malleability of the brain is so important 
that a lack of neuroplasticity has been linked to diseases such as 
Alzheimer’s (Mesulam, 1999). 
Cognitive ability requires structural and functional cooperation of 
the brain. As deviations in structure and function are recorded, so is the 
variation among these deviations. Each study mentioned earlier found 
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trends in functional and anatomical differences, but not one study found 
a single straight-forward consistent difference. Brain maturation requires 
years of nutritional development, environmental stimulation, and a 
sound genetic infrastructure (Plomin & DeFries, 1998). Genes specifically 
responsible for brain development and neurological function may 
underlie developmental stuttering, as these genes too are 
environmentally responsive during the critical stages of pre-natal and 
post-natal development. A balanced view, in which nature and nurture 
interact during this development in a final common pathway, could 
produce the variations observed in affected individuals.  
 
2. Oligogenic Theory 
 
In recent years, oligogenic traits have gained some attention. 
Specifically, these are complex traits with a smaller number of 
contributing genes, one or more of which might be a major susceptibility 
locus, whose expression is influenced by the environment as well as 
other genes. For some oligogenic diseases, the major susceptibility loci 
may be different for different families. Genetic studies of stuttering are 
consistent with the possibility that it is an oligogenic trait.  
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3. An Addiction Model 
 Scientists have reportedly found genes linked to addiction. 
Whether these genes are specific to food addictions, substance abuse, or 
obsessive compulsive disorder, they all demonstrate incomplete 
penetrance and threshold characteristics that make someone more or 
less vulnerable to addictive behaviors. There is the presumption that for 
affected individuals a difficulty exists in their ability to execute a 
cessation of behaviors once they start. In light of the findings, the genetic 
pre-disposition for addiction does not doom the individual to inevitably 
become an addict, but rather that an interplay between the genes and 
the environment determines addiction risk. 
Like many other behavioral diseases, addiction vulnerability is a 
complex trait (Enoch & Goldman, 1999). Several genes have been 
discovered through the use of animal models. See Table 2.8 for a 
summary of genes linked to alcohol and cocaine.  
 
 
 
 
 
 
 
36
 
 
Table 2.8 Genes associated with alcohol and drug addiction 
Study Gene Function 
Goldman, Brown,  
Albaugh, Robin  
Goodson, Trunzo  
Akhtar, Derse, 
Long, Linnoila, & 
Dean, 2006   
DRD2 
The A1 allele of the dopamine receptor 
gene DRD2 is more common in people 
addicted to alcohol or cocaine. 
 
Fehr, Grintschuk, 
Szegedi, 
Anghelescu, 
Klawe, Singer, 
Hiemke, & 
Dahmen, 2000 
Htr1b 
Mice bred to lack the serotonin receptor 
gene Htr1b are more attracted to cocaine 
and alcohol. 
 
Epping-Jordan, 
Picciotto, Jean-
 Changeux & Pich, 
1999 
β2 
Mice bred to lack the β2 subunit of 
nicotinic cholinergic receptors have a 
reduced reward response to cocaine. 
 
Thiele, Marsh, 
Marie, Berstein, & 
Palmiter, 1998 
neurope
ptide Y 
Mice with low levels of neuropeptide Y 
drink more alcohol, whereas those with 
higher levels tend to abstain. 
 
Rothenfluh & 
Heberlein, 2002 tyramine 
Fruit flies mutated to be unable to 
synthesize tyramine remain sedate even 
after repeated doses of cocaine. 
 
Spanagel, 
Pendyala, Abarca, 
Zghoul, Sanchis-
Segura, Magnone, 
et al., 2005 
Per2 
Mice mutated with a defective Per2 gene 
drink three times more alcohol than 
normal. 
 
Crabb, 
Edenberg, 
Bosron, & Li, 
1989 
ALDH*2 
Alcoholism is rare in people with two 
copies of the ALDH*2 gene variation. 
 
Modified from Genetic Science Learning Center, 2009  
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Although we are unable to make mice stutter, or use other animal 
models to investigate the genetics of developmental stuttering3, the mode 
of genetic integration in addiction makes an interesting analogy. Table 
2.8 outlines several genes acting independently of each other, which all 
contribute to the same phenotypic behaviors and outcomes. When 
looking specifically at the genes, it can be seen that some are mutations, 
others are replication variations, while others are normal alleles found 
among both affected and unaffected individuals.  
Stuttering has several potential similarities, especially if one 
examines the genetically instigated reward system.  Noble, Blum and 
colleagues (1990) identified the D2 dopamine receptor (DRD2) 
polymorphism to contribute to risk of severe alcoholism. Later studies 
linked the A1 variation of the DRD2 gene to a large percentage of 
alcoholics, drug abusers, smokers, and other addictive, compulsive or 
impulsive disorders. This gene affects dopamine receptors, and positively 
reinforces repetitive behaviors in an individual regardless of external 
judgment of benefit.  The likelihood of identifying specifically the role 
DRD2 in people who stutter is quite low. This does not diminish, 
however, the potential of other shared genes with addiction disorders 
that may exist to contribute to our understanding of stuttering 
                                                 
3 Professor David Clayton at the University of Illinois has been able to simulate stuttering in Australian 
zebra finch songbirds (2006, personal communication). His work, along with that of and Kobayashi, 
Hiroyuki, and Okanoya (2001), (who were able to simulate stuttering in Bengalese finches) does not 
contribute to genetic or functional knowledge of developmental stuttering as the stuttering generated in 
these songbirds was lesion based.  In both cases, lesions were made in the anterior forebrain of region X 
and resulted only in sound repetitions in the bird’s song. 
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behaviors. 
 
Goals 
The aim of this study is: 
1) to identify replicable candidate genes that influence the 
risk of individuals to stutter. 
2)  to investigate the pathways in which these genes 
function to disrupt the fluent production of speech. 
 
Rationale 
 
One of the three models discussed earlier or any combination of 
the three models may potentially explain the underlying cause of 
stuttering. Elements of each model provide reasonable elements 
supporting the phenotypic characteristics and patterns of heritability 
currently observed in the disorder. Instead of pursuing a transmission 
model, which has in the past yielded inconclusive results, this study 
aims to identify specific genes contributing to the risk of stuttering.  As 
exemplified in the discovery of FOXP2, a small discovery set of genes has 
the potential to lead researchers to concrete evidence of specific gene 
contribution/involvement and neuro-genetic relationships. 
Presently there is no consensus regarding which transmission 
model, chromosomes, genes, alleles, or sex factors are involved in the 
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expression of stuttering. A GWAS screens “without any prior predilection 
for specific regions, genes, or variants thereof” (Kitsios & Zintzaras, 2009, 
p. 161). In fact, GWAS have been referred to as a “hypothesis-free” 
approach (Hunter et al., 2008; Pearson & Manolio, 2008), making it an 
ideal candidate for this complex disorder.  
Linkage studies are not as powerful as association studies for the 
identification of genes contributing to the risk for complex diseases 
(Risch & Merikangas, 1996).  A whole-genome case-control association 
study for genes involved in the disorder of stuttering is the next logical 
step in identification. To maximize the chance of success, subjects with 
clearly defined persistent phenotypes will be chosen for affected cases.  
 
Hypothesis 
 
Based on current literature and purposed theories mentioned 
earlier, three functional categories of genes are predicted:  
1. Neural development  
2. Neural function (e.g. transport genes or hormones) 
3. Behavioral genes (specifically implicated phenotypically in addiction)  
 
A study which produces replicable findings congruent with sound 
theory and evidence would be invaluable to the future of stuttering both 
clinically and scholarly. “Moreover, identification of genetic risk factors 
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will aid in the design of epidemiological studies that might identify non-
genetic risk factors for stuttering that could be targets for cost-effective 
prevention strategies” (Cox, 2004, personal communication). 
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Chapter 3 
Methods 
 
Subjects 
 
One hundred and twenty two experimental subjects ages 13 to 70 
years were recruited from two primary sources. Seventy-six unrelated 
individuals of European descent already recruited in a previous linkage 
study of stuttering (Suresh, Ambrose, Roe, Pluzhnikov, Wittke-
Thompson, Ng, Wu, Cook, Lundstrom, Garsten, Ezrati, Yairi, & Cox, 
2006) were combined with 46 new subjects recruited through the 
University of Illinois Stuttering Research Program under a current NIH 
funded cross-sectional study of stuttering.  One hundred and seven 
control subjects’ data were downloaded from www.HapMap.org. This 
database includes detailed genetic information for trios of family 
members, typically a mother, father, and child. Unrelated individuals 
(mothers and fathers) were used. These subjects were coded CEU (CEU – 
CEPH samples of European descent living in Utah, USA).  A record of 
participants is listed in Table 3.1. It is unknown if any of these 
individuals are affected with stuttering. They represent a general 
population sampling and it is conceivable that one or two individuals in 
this sample would be affected/or recovered from the disorder of interest. 
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Table 3.1 Demographic Data of Participants 
Ethnic 
Group N Sex Status Recruited 
Included in 
GWAS 
European 35 Male:      29 Female:    6 Persistent UIUC Y 
European 49 Male:      31 Female:  18 Persistent 
Suresh et al., 
2006 Y 
European 
(Israel) 27 
Male:      24 
Female:    3 Persistent 
Suresh et al., 
2006 N 
European 
CEU 107 
Male:      54 
Female:  53 Control HapMap Y 
African 
YRI 108 
Male:      56 
Female:  52 Control HapMap N 
Asian 
CHB+JPT 105 
Male:      54  
Female:  51 Control HapMap N 
African 
American 4 
Male:      3 
Female:  1 Persistent UIUC N 
Asian 5 Male:      4 Female:  1 Persistent UIUC N 
Other 2 Male:      2 Female:  0 Persistent UIUC N 
*Some participants were not included in the final GWAS due to ethnicity, lack of matched 
controls, or failed quality control measures. Some samples included in this table from 
HapMap were used only for EIGENSTRAT analysis and ethnicity verification. 
 
 
 
Selection Criteria: Diagnosis of Stuttering 
 
For each potential participant, stuttering was verified by a co-PI of 
the grant or a highly specialized Speech-Language Pathologist with 
expertise in stuttering and related fluency disorders.  Individuals 
identified for this study were required to meet one or more of the 
following criteria: (a) direct observation of stuttering by the investigators 
in person or via telephone, (b) diagnosis and/or treatment of stuttering 
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by a speech-language pathologist or (c) detailed description of stuttering 
behaviors by the participant judged sufficient to positively identify 
stuttering.  In addition, only participants with persistent stuttering were 
used. This required each subject to (a) self-report or (b) observably 
continue to exhibit stuttering behaviors.  
This diagnostic criteria was also used in the Suresh et al. (2006) 
study to diagnose persistent developmental stuttering in those 
participants. Seventy-six participants from Suresh et al. (2006) were 
included in the present study, therefore, diagnostic standards among the 
combined participants were strictly maintained. 
 
Data Collection/ Data Access 
 
Individuals who stutter were recruited through the Illinois 
International Stuttering Research Program, the University of Illinois 
Speech Language Pathology Clinic, newspaper ads, and personal 
referrals of colleagues. These participants were given a preliminary 
stuttering diagnosis screening consisting of criteria listed above. Upon a 
confirmed diagnosis, 10 ml of blood was drawn at a medical clinic by a 
physician or phlebotomist from an antecubital vein into two 5 ml plastic 
vacutainer tubes or 2 ml of saliva was collected with an OrageneDNA Spit 
Kit by the investigator.  Control subject data are available to academic 
researchers in a web-based database (www.hapmap.org). 
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Extraction 
 
 DNA from blood and saliva samples was extracted at the University 
of Chicago. Blood samples were stored in a -80°C freezer until sample 
collection was complete. Using a PureGene DNA extraction kit (Gentra, 
Qiagen Inc., Valencia, California), blood samples were thawed, purified, 
and DNA was isolated for polymerase chain reaction (PCR) and 
genotyping. The PureGene cell kit enables purification of high-molecular-
weight (100–200 kb) DNA to be suitable for high-density genotyping. The 
purification procedure removes enzyme inhibitors and contaminants 
from the sample improving the quality of the sample for more accurate 
genotyping results. PCR enables the production of millions of copies of 
specific DNA sequences. Once DNA is replicated, it can be applied to a 
microchip gene array for genotyping.  
 DNA from saliva samples were extracted using OrageneDNA 
extaction protocol for 4.0mL samples (Genotek Inc., Ottawa, Onterio, 
Canada). Samples were stored at room temperature then were weighted 
and incubated in 50°C water bath for 2 hours before undergoing the 
purification and extraction process.  
A NanoDrop spectrophotometer cuvette was used to ensure proper 
molecular weight of the extracted DNA from the saliva samples. This step 
verifies that the sample is suitable for downstream applications, 
including PCR and genotyping.  Absorbance values (of light) at 260 nm 
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were accepted between 0.1 and 1.5. These values reflect those of good 
quality samples yielding an expected molecular concentration range of 20 
to 200 ng/μL. All saliva samples passed this quality-control check. 
 
Genotyping 
 
All genotyping in the case samples was performed with the 
Affymetrix 6.0 SNP chip which allows researchers assay up to 906,600 
single nucleotide polymorphisms (SNPs) and more than 900,000 
additional genomic features for assessment of copy number variants 
(CNVs) across the human genome (Li, Li, & Guan, 2008). According to 
the manufacturer’s guidelines, we used 250 ng genomic DNA to genotype 
each sample. On day 1, samples are cut with a restriction enzyme and 
ligated to adapters. A generic primer is applied that recognizes the 
adapter sequence and selectively amplifies fragments within a certain 
size range. This reduces the complexity of the genome down to usable 
portions. On day 2, the amplified DNA is then fragmented, labeled, and 
hybridized to the array. Very little DNA is needed (250 ng) to assay a 
large number of SNPs with high call rates (>99%)( Korn, Kuruvilla, 
McCarroll, Wysoker, Namesh, et al., 2008). Genotypes were called using 
the Birdseed genotype calling algorithm (Korn, et al., 2008). 
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Quality Control 
 
Initial quality control of the samples focused on identifying and 
flagging poor quality data; we removed samples missing 10% or more 
genotypes across all SNPs and SNPs missing in at least 10% of all 
individuals.  In addition, we removed samples with disproportionate (high 
or low) heterozygosities relative to the distribution of heterozygosity 
across all samples and flagged SNPs with highly significant departures 
from Hardy Weinberg equilibrium. Previously unknown relatedness 
between subjects was examined by looking at IBD (identidy by descent) 
in all individuals considered pairwise.  This procedure also indentified 
any duplicated samples in the study.   
The HapMap control samples and the previously collected samples 
from Suresh et al. (2006) were from pools of related individuals. 
Verification of reported sex was examined by looking at the inbreeding 
coefficient F for the sex chromosomes of each individual in order to help 
insure that the correct unrelated samples were being examined.  
The statistical formula is based from:   
Fst ~ (π0 – (π1+ π2)/2)/ π0) 
Where π0 is the nucleotide diversity in the whole population and (π1+ 
π2)/2 is the average of the nucleotide diversity in the 2  
subpopulations we are looking at.  This is a general statistic to 
population genetics but here it is used to determine sex.  For a female 
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with XX, they will have a nucleotide diversity roughly that of the whole 
population or autosome (π0), so F = 0 and in XY males they all look like 
homozygotes so (π1+ π2)/2 = 0 so F = 1.  
 
Principal Components Analysis 
 
Principal components analysis was performed using the 
EIGENSTRAT software (Price, Patterson, Plenge, Weinblatt, Shadick, & 
Reich, 2008).  In initial analyses to identify potential population 
substructure, we included HapMap samples of European descent (CEU – 
CEPH samples of European descent living in Utah, USA), African descent 
(YRI – samples from Yoruba living in Ibadan, Nigeria), and Asian descent 
(CHB and JPT – samples from Han Chinese living in Beijing, China and 
samples from Japanese living in Tokyo, Japan) along with those from our 
subjects who were ascertained for current or past stuttering.  This initial 
analysis allows for the identification of individuals of recent European 
descent. The non-European samples were then removed once ancestry 
had been determined, and the European samples (including controls) 
were then analyzed using EIGENSTRAT software. The original QQ plot (a 
quantile-quantile (QQ) plot is a graphical technique for determining if two 
data sets come from populations with a common distribution) showed 
some deviations from the predicted standard regression line. We 
excluded the Israeli samples and reran EIGENSTRAT. The Israeli 
 
 
48
 
 
samples did not appear to be covariates, so they were excluded from the 
study.  EIGENSTRAT was rerun using only samples of European descent 
and the resulting eigenvectors were used as covariates in the association 
studies to insure that results were not compromised by inappropriate 
matching of European descent cases and controls.  
 
Data Analysis 
 
A computer software program, PLINK (Purcell, Neale, Todd-Brown, 
Thomas, Manuel, et al., 2007), was used for data analysis. Chi-square 
tests were performed to assess frequency differences between cases and 
controls.  SNPs with p-values < 10-3 were annotated for function and any 
genes in Linkage Disequilibrium with the SNP4.  These SNPs were 
annotated for any genes for which the SNP is an expression quantitative 
trait locus (eQTL). In other words, certain SNPs are known to predict the 
expression of a certain gene and are known as eQTLs.   
 
Statistical Analysis 
Primary Analysis  
 
Significance of association between the disease phenotype and 
                                                 
4 Linkage Disequilibrium occurs when two genes are seen together more often than they 
should be if they were unlinked. This is a strong suggestion that the genes in question 
are not randomly associated with each other and may be implicated in the genotype of 
interest. 
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each SNP was assessed using logistical regression as implemented in 
PLINK.  Eigenvectors specific to individuals of European descent were 
used as covariates in the analysis.  Individuals from Israel were removed 
from the analysis because QQ plots revealed an over-inflation of p-values 
even with correction for population stratification using eigenvectors as 
covariates.  
 
Candidate-Gene Analysis 
 
 Candidate genes were selected via identification of regions 
demonstrating allele (or haplotype) frequency differences between the 
experimental and control groups. In addition, SNPs on the GeneChip 
array were distinguished with those that were identical to regions 
identified in previous studies as showing an association with stuttering.  
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Chapter 4 
Results 
 
 
Principal Components Analysis 
 
 Principal components analyses were performed using EIGENSTRAT 
to detect population substructure. Four control HapMap populations, 
CEU (European), CHB(Chinese), JPT(Japanese), and YRI(Yoruba), were 
used to genetically determine ancestry of affected stuttering individuals.  
Substructure present in experimental samples of European ancestry 
caused two local clusters on the primary and second eigenvectors 
overlapping and neighboring the CEU controls (the samples are indicated 
in Figure 4.1) One cluster overlaps with the CEU controls (indicated in 
Figure 4.1 by a red circle).  Experimental samples clustering adjacent to 
the CEU control sample were confirmed to be of self reported Isreali 
descent.   
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Figure 4.1 EIGENSTRAT Analysis of Ancestry 
 
  Several experimental subjects were observed to be of Asian, 
African, and mixed ancestry. These subjects were removed from further 
statistical analysis and the GWAS to prevent possible false positive 
results due to population substructure.   
 
Association Analysis 
 
 The original QQ plot of all European affected subjects (Isreali and 
western Eueropean) displayed a large dispersion from the expected p-
values of the regression identity line (Figure 4.2).  
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Figure 4.2 Original Quantile-Quantile Plot of European Ancestry 
           
 Deviation from the diagonal identity line suggests that either the 
assumed distribution is incorrect or that the sample contains values 
arising from true associations. The magnitude of this variation suggests 
that this dispersion is not due to true associations, but to significant 
differences in population structure or, in this case, an over-correction of 
p-values. An over-correction can be detected by observing p-values that 
deviate below the line toward the expected side. This indicates lower p-
values on average than would be expected, suggesting that too many 
eigenvectors are being used as covariates and the resulting values are too 
conservative. The Israeli samples are likely very similar to the rest of the 
European samples differing at only a small number of SNP sites. If the 
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additional eigenvector is used to account for the small but significant 
ancestry differences, all SNPs are corrected based on these differences 
when most sites don’t need this correction.  Hence, Israeli samples were 
removed (n = 27), thus correcting for ancestry variance and the corrected 
QQ-plot (Figure 4.3) demonstrates an ideal plot with very little 
dispersion. Points observed outside of the gray area (the 95% confidence 
interval) are assumed to be associated with the disease of interest.    
 
Figure 4.3 Corrected Quantile-Quantile Plot of Strict Northern European    
Ancestry 
         
 Statistical Analysis 
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 PLINK software indentified 97 SNPs from the GWAS with p-values 
less than 10-3 significance in the stuttering population. Within this 
subset, SNPs with a p-value less than 10-4 and greater than 10-8 were 
considered (72 SNPs) per standard Bonferroni correction. Of these SNPs, 
only 22 contained known genes. 
 
Table 4.1 Statistically Significant SNPs Showing Association with 
Persistent Developmental Stuttering 
Chromosome SNP BP p-value Gene/ 
function 
1 rs4341397 56177988 2.85e-05 NA 
1 rs1028400 206180354 3.08e-05 NA 
1 rs1212304 206185202 4.76e-05 NA 
1 rs10888965 56522669 5.98e-05 NA 
1 rs778384 56409754 6.37e-05 NA 
1 rs778417 56417155 6.37e-05 NA 
1 rs12035224 206196311 6.99e-05 NA 
1 rs4927315 56543494 7.20e-05 NA 
1 rs2745967 206195345 7.73e-05 NA 
1 rs16830063 198450969 1.16e-04 NA 
2 rs10203329 223058245 1.15e-05 SGPP2 
2 rs12052330 235832565 2.14e-05 NA 
2 rs11781317 122351199 2.81e-05 NA 
2 rs840950 65572319 4.88e-05 NA 
2 rs6727792 53558145 6.40e-05 NA 
2 rs7575607 31493959 6.57e-05 NA 
2 rs840952 65573445 8.70e-05 NA 
2 rs2573111 125682936 1.24e-04 NA 
2 rs13028172 196440546 1.306e-04 DNAH7 
3 rs7428796 86338362 9.06e-07 NA 
3 rs524438 119602372 4.23e-05 NA 
3 rs6809248 52284378 7.23e-05 WDR82 
4 rs4861810 180938089 1.22e-05 NA 
4 rs12331487 97711397 1.92e-05 NA 
4 rs1585273 180938584 6.86e-05 NA 
4 rs9884651 27575780 7.74e-05 NA 
4 Rs10032173 27593263 1.12e-04 NA 
4 Rs2019467 13902990 1.17e-04 NA 
5 Rs10463397 147502740 1.71e-06 NA 
5 Rs12655124 153802728 1.26e-04 NA 
6 Rs4714735 44133677 3.04e-06 NA 
6 Rs2326574 4986469 1.71e-05 LOC100129 
6 Rs2994694 4980651 2.17e-05 LOC100129 
6 Rs2793240 4948179 8.31e-05 RPP40 
6 Rs795809 4965672 8.31e-05 NA 
6 Rs2764114 4996182 1.25e-04 NA 
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Table 4.1 (Cont.) 
7 Rs10231824 131572872 2.94e-05 PLXNA4 
7 Rs10254737 131583166 4.82e-05 PLXNA4 
7 Rs6944400 131583025 6.98e-05 PLXNA4 
7 Rs6467426 131561969 1.21e-04 PLXNA4 
7 Rs1349406 131558291 1.29e-04 PLXNA4 
8 Rs17517144 18377514 1.30e-05 NA 
8 Rs6577921 139491434 4.09e-05 FAM135B 
8 Rs7828809 139492089 4.09e-05 FAM135B 
8 Rs17517777 18468696 8.70e-05 PSD3 
8 Rs17596083 18468372 1.14e-04 PSD3 
8 Rs10503616 18463721 1.30e-04 PSD3 
9 Rs4744783 77971147 1.18e-05 PCSK5 
9 Rs1411956 77967757 3.70e-05 PCSK5 
9 Rs3903907 114764370 6.10e-05 LOC100129 
9 Rs4978523 114763299 1.00e-04 LOC100129 
9 Rs1330042 117153667 1.15e-04 NA 
10 Rs17114000 90645089 2.31e-07 STAMBPL1 
10 Rs10996890 67522056 2.52e-05 CTNNA3 
10 Rs10996884 67515943 6.62e-05 CTNNA3 
10 Rs10736957 305525 1.05e-04 NA 
10 Rs17156343 1468227 1.29e-04 ADARB2 
11 Rs7119667 61391128 2.23e-06 FADS2 
11 Rs562028 59634426 9.87e-05 NA 
11 Rs10897020 59794143 6.05e-05 NA 
12 Rs11104852 87318456 3.12e-06 NA 
12 Rs11169953 50590666 4.75e-05 ACVRL1 
12 Rs4964826 103539674 2.45e-05 CHST11 
12 Rs10507177 103533038 8.90e-05 CHST11 
13 Rs9600564 75333636 9.60e-06 NA 
13 Rs12584838 27109308 8.01e-05 POLR1D 
14 Rs10133907 21689758 5.26e-05 NA 
14 Rs9323108 21723598 9.10e-05 NA 
14 Rs2415328 35958283 1.14e-04 NA 
15 Rs11072923 78587211 5.20e-05 ARNT2 
15 Rs12148477 49440411 6.21e-05 GLDN 
15 Rs12593365 30895282 1.11e-04 FMN1 
16 Rs1566184 74517245 3.73e-05 NA 
17 Rs4306569 29853048 1.26e-04 NA 
18 Rs6508606 25465343 2.64e-05 NA 
18 Rs8097651 25486009 1.03e-04 NA 
19 Rs3764557 15731246 9.04e-05 NA 
20 Rs6094607 45206827 1.38e-05 EYA2 
20 Rs6081636 19474066 2.11e-05 SLC24A3 
20 Rs13045300 19745047 3.54e-05 NA 
20 Rs6037460 304785 4.35e-05 NA 
20 Rs1008031 45226938 5.13e-05 EYA2 
20 Rs6051550 305570 6.10e-05 NA 
20 Rs6139982 6359560 8.75e-05 NA 
20 Rs4810619 45218428 1.04e-04 EYA2 
20 Rs6085561 6377864 1.12e-04 NA 
20 Rs6066218 45224368 1.14e-04 EYA2 
20 Rs3790224 19405878 1.24e-04 SLC24A3 
23 Rs2335791 35586481 7.94e-05 NA 
23 Rs5928966 35602838 8.42e-05 NA 
23 Rs5970769 23573835 1.25e-04 NA 
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Associations were plotted as –log10 P values for GWAS in 84 cases 
with developmental stuttering and 107 controls, showing single data 
points for SNPs with P<10-4 (horizontal red line) for 22 autosomes and 
the X chromosome. SNPs between the lower limit of P<10-4 and the upper 
limit of P>10-7 were considered for candidate gene analysis. 
 
Figure 4.4 Manhattan Plot of SNPs 
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Candidate-Gene Analysis 
 
Candidate genes were selected among the SNPs demonstrating 
haplotype frequency differences between the affected and control samples 
within the selected p-value criteria.  SNPs were filtered for minor allele 
frequency <0.01 (MAF), genotype call rate <0.05, and Hardy-
Weinberg<10e-8.  SNPs are filtered out for very low minor allele 
frequencies of less than 1% for two reasons: 1) there is very little power 
to detect an association with a low MAF SNP and 2) because genotyping 
calls are not as reliable for low frequency alleles and may be due to a 
genotyping error.  The genotype call rate is filtered to only look at SNPs 
where at least 95% of the genotypes included that SNP. If a SNP gets “no 
call” more than 5% of the time in subjects, it doesn’t lend itself to 
genotyping reliability and may not have been correct when it was called. 
The Hardy-Weinberg filter checks if SNPs are significantly out of Hardy-
Weinberg equilibrium (HWE).  SNPs out of HWE are more likely to be 
spurious and/or a genotyping error than a true association.  Candidate 
gene results are listed below in Table 4.2. 
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Table 4.2 Candidate Genes/SNPs in association with persistent 
developmental stuttering 
Gene 
Chro
moso
me 
SNP BP p-value function 
FADS2 11 rs7119667 61391128 2.23e-06 fatty acid desaturase 2 
PLXNA4 7 rs10231824 131572872 2.94e-05 plexin A4 
CTNNA3 10 rs10996890 67522056 2.52e-05 
catenin 
(cadherin-
associated 
protein), alpha 3 
ARNT2 15 rs11072922 78587211 5.20e-05 
aryl-hydrocarbon 
receptor nuclear 
translocator 2 
EYA2 20 rs6094607 45206827 1.38e-05 
eyes absent 
homolog 2 
(named for its 
initial 
discovery/functio
n in Drosophila) 
PCSK5 9 rs4744783 77971147 1.18e-05 
proprotein 
convertase 
subtilisin 
SLC24A 20 rs6081636 19474066 2.11e-05 
solute carrier 
family 24 
(sodium/potassi
um/ 
calcium 
exchanger 
N/A 
 2 rs2573111 125682936 1.02e
-04 
N/A 
may be 
associated with 
CNTNAP5 
FMN1 15 rs12593365 30895282 1.11e-04 forming 1 
ADARB2 10 rs17156343 1468227 1.29e-04 
adenosine 
deaminase, RNA-
specific, B2 
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Figure 4.5 Manhattan Plot of Candidate Genes/SNPs in Association with 
Persistent Developmental Stuttering 
          
  
In addition, SNPs on the GeneChip array were distinguished with 
those that were identical to regions identified in previous studies as 
showing an association with stuttering. 
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Table 4.3 GWAS overlap with previous studies 
Study Most Important Chromosome 
Other 
Chromosomes 
Potential GWAS 
match 
Shugart et 
al., 2004 
 
18 1, 2, 10, and 13 
rs2573111, 
ADARB2, 
CTNNA3 
Riaz et al., 
2005 
 
12 1, 5, 7, 12 PLXNA4 
Suresh et 
al., 2006 
9, 15, and 
conditionally 2 
Male specific on 
7, Female 
specific on 21 
PCSK5, ARNT2, 
PLXNA4, 
rs2573111 
Wittke-
Thompson 
et al., 2007 
 
13 1, 3, 5, 9, 13, 15 PCSK5, ARNT2 
*Highlighted chromosomes represent candidates for potential genetic 
overlap. 
 
 On Chromosome 7, Suresh et al. (2006) reported LOD significance 
for CLCN1 which overlaps by cytogenetic region with PLXNA4 at 7q32.3. 
Riaz et al. (2005) also reported a region on chromosome 7 at 7q36.3. This 
region does not overlap with any regions in the current study, but was 
found to regulate PLXNA3 (not PLXNA4 as identified in the GWAS, but in 
the same family) and ARNT genes. Unfortunately, several of the linkage 
studies did not provide enough information regarding the location of 
their chromosomal regions of interest.  Overlap with other speech and 
language disorders, addiction disorders, neurological disorders was 
found to be associated with several of the genes found to be significant in 
the current study. See Table 4.4 below. 
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Table 4.4 Overlap genes with other disorders 
Gene Chromosome Function Overlap Study 
FADS2 11 
Desaturase enzymes 
regulate unsaturation of 
fatty acids through the 
introduction of double 
bonds between defined 
carbons of the fatty acyl 
chain. 
ADHD 
Brookes, Chen, 
Xu, Taylor, & 
Asherson, 2006 
PLXNA
4 7 
Inhibitory signaling 
molecule in the brain 
Autism, 
Obesity 
Maestrini, 
Pagnamenta, 
Lamb, Bacchelli, 
Sykes, Sousa, et 
al., 2009; 
Laramie & 
Matthew, 2008 
CTNNA
3 10 N/A 
Late-onset 
Alzheimer’s 
disease 
Morgan, 
Hamilton, Turic, 
Jehu, Harold, 
Abraham, et al., 
2008; 
Miyashita, Arai, 
Asada, Imagawa, 
Matsubara, 
Shoji, Higuchi, et 
al., 2007 
ARNT2 15 
A transcription factor 
that acts as a partner 
for several sensor 
proteins in the bHLH-
PAS family. Primary 
function in genes 
responsive to 
developmental and 
environmental stimuli. 
Autism  
 
Chakrabarti, 
Dudbridge, Kent, 
Wheelwright, 
Hill-Cawthorne, 
Allison, et al., 
2009 
EYA2 20 
The encoded protein 
may be post-
translationally modified 
and may play a role in 
eye development. 
SLI, 
Alcoholism 
Joslyn, 
Ravindranathan, 
Brush, Schuckit, 
& White, 2010 
PCSK5 9 
processes sugars in the 
brain, and predicts 
expression of SLC24A3 
N/A N/A 
SLC24
A3 20 
transporter signaling 
molecule in the brain N/A N/A 
FMN1 15 N/A Alcoholism 
Kitahara, Kawa, 
Katsuyama, 
Umemura, 
Ozaki, 
Takayama, et al., 
2008 
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Table 4.4 Overlap genes with other disorders (cont.) 
 
 
Gene Chromosome Function Overlap Study 
ADARB2 10 
This gene 
encodes a 
member of the 
double-
stranded RNA 
adenosine 
deaminase 
family of RNA-
editing 
enzymes and 
may play a 
regulatory role 
in RNA editing 
Late- onset 
Alzheimer’s 
disease 
Grupe, Li, 
Rowland, 
Nowotny, 
Hinrichs, 
Smemo, 
Kauwe, et al., 
2006 
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Chapter 5 
Discussion 
 
 
 A GWAS was performed investigating 906,600 SNPs in 84 
Caucasian northern European subjects characterized for their diagnosis 
of persistent developmental stuttering and 107 matched controls who do 
not stutter. As stated previously in the methodology, a systems biology 
analysis focusing on the functional categories of significant SNPs was 
used to approach the data. Rather than focus on the individual 
SNPs/genes, evidence to support functionally related sets of genes was 
sought to determine candidate genes contributing to the pathology of 
persistent developmental stuttering.  This was tested by individually 
investigating each statistically significant SNP for function and cross-SNP 
prediction or regulation.  To perform this analysis, 97 SNPs were placed 
in a ranked list sorted from lowest to highest p-values according to 
association p-values within the desired confidence interval. Candidate 
genes were classified into three predicted functional categories: neural 
development, neural function (e.g. transport genes or hormones), and 
behavioral genes (specifically implicated phenotypically in addiction (see 
Table 5.1)).    
It should be noted that several candidate genes fit into more than one 
functional category. For example FMN1 plays a large role in brain 
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development but has also been linked to alcoholism. 
 
Table 5.1 Functional categories of candidate genes 
Category Gene Function 
Neural Development FADS2 
 
 
CTNNA3 
 
EYA2 
 
 
 
FMN1 
 
 
ARNT2 
Metabolizes fatty acids in the 
brain during development 
 
Mediates strong cell-cell 
adhesion 
 
Regulates transcription during 
critical stages of embryonic 
development 
 
Cytoskeletal formation, cell 
migration, and gene expression 
 
Regulates fetal neurogenesis  
Neural Function PLXNA4 
PCSK5 
SLC24A 
ADARB2 
 
ARNT2 
Inhibitory signally molecule 
Processes sugars  
Signaling molecule 
Changes amino acid sequences 
predicted by genes 
 
Regulates neuroendocrine 
system 
Behavioral Function FMN1 
 
EYA2 
 
Functions in neural 
development, behavioral 
implications in Alcoholism 
 
Functions in neural 
development, behavioral 
implications in Alcoholism 
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Neural Developmental Genes 
 
 Fatty acid desaturase 2 (FADS2, rs7119667) is located on the long 
arm of chromosome 11 (11q12-q13.1) and comprise 39.113 nucleic 
bases.  FADS2 was found in this study to be significant at p=2.23e-06 , 
but has not been indentified in previous linkage studies of stuttering. 
Fatty acids have been found to “affect behavior and cognition both 
directly and indirectly” (Brookes, Chen, Xiaohui, Taylor & Asherson, 
2006, p. 1053). The human brain composition is approximately 60% lipid 
(Settle, 2002).  According to Hallahan and Garland (2005), fatty acids 
play a key role in modulating neural function and development as well as 
cognitive and behavioral development. Brookes et al. (2006) found FADS2 
to be significantly associated with ADHD. As in addiction disorders, 
ADHD is thought to be altered by the amount of available dopamine at 
the synapse (Goldman et al., 2006). Interestingly, some studies 
conducted on the neuronal response of dietary fatty acids have shown 
resulting alterations in dopamine neurotransmission (Brookes et al., 
2006).  Investigations of individuals deficient in omega-3 fatty acids have 
reported a reduction in dopamine concentrations in the prefrontal cortex 
(Delion, Chalon, Guilloteau, Besnard, & Durand, 1996; Zimmer, 
Vancassel, Cantagrel, Brenton, Delamanche, Guilloteau, et al. (2002). 
Animal studies of ADHD and fatty acids have confirmed this observation 
(Russell, Villiers, Sagvolden, Lamm, & Taljaard, 1995; Sagvolden, 2000).  
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 Several studies have linked brain development and intelligence to 
the environmental exposure to fatty acids in breast milk (Anderson, 
Johnstone, Remley, 1999; Caspi, Williams, Kim-Cohen, Craig, Milne, 
Poulton, et al., 2007; Mortensen, Michaelson, Sanders, & Reinisch, 
2002). Caspi and colleagues (2007) found that the association between 
breastfeeding and intelligence was solely moderated by FADS2. The 
study ruled out alternative explanations including exposure, intrauterine 
growth, social class, maternal cognitive ability and genetic differences in 
breast milk composition. The role FADS2 plays in modifying dietary fatty 
acids is substantial for brain development. The gene is the rate-limiting 
step in the metabolic pathway of fatty acid modification into arachidonic 
acid and docosahexaenoic acid, better known as DHA. Substantial 
amounts of these two compounds are produced in the human brain 
during the first few months of development following birth (Heird & 
Lapillonne, 2005). Evidence supports the observation of children with 
higher levels of DHA and arachidonic acid to have enhanced cognitive 
development through early childhood (McCann & Ames, 2005) that 
produces cognitive benefits into adulthood as longitudinally reported by 
IQ scores (Mortensen, et al., 2002). 
A study investigating breastfeeding in children who stutter was 
recently conducted at the University of Illinois by Smith and Ambrose 
(2009). A questionnaire was administered to mothers of children who 
stutter regarding breastfeeding initiation, exclusivity, and duration. The 
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results supported the hypothesis that breastfeeding provides a measure 
of protection against persistent developmental stuttering. The role fatty 
acids play in regulating gene expression by altering the availability of 
transcription factors was highlighted (Jump, 2004; Oddy, 2006). In 
addition, authors suggested that an underlying mechanism of stuttering 
may be attributed to the differences observed in the neural tissue of 
formula-fed infants. Formula fed infants have a higher ratio of fatty acids 
that are not broken down into usable forms of DHA and may be 
associated with subtle impairments in neurotransmission, cell-to-cell 
signaling, and synaptic membrane function (Oddy, 2006).  
 The role of FADS2 in stuttering is not explicitly evident, however, 
it’s impact on brain development and function is undeniable. FADS2 
appears to be very active in brain development through the early 
childhood years which correlates to stuttering onset, and for most 
children natural recovery. The evidence of FADS2s influence on 
cognition, behavior and dopamine transport paired with its involvement 
in DHA production (known to improve memory and learning processes) 
into adulthood would support potential involvement in adults with 
persistent developmental stuttering. 
 
Neural Function Genes 
 
PCSK5 is a pro-protein convertase subtilisin located medially on 
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the long arm of chromosome 9 (rs4744783, 9q21.3) consisting of 302,724 
nucleic bases.  It is known to process glycoproteins in the brain (Cao, 
Mok, Miskie, & Hegele, 2001). Glycoproteins act as hormones, enzymes, 
carriers, and/or inhibitors, among other roles. Not much is known about 
the specific function of this gene or its interaction with sugars in the 
brain, however, it does regulate the expression of SLC24A3 another 
candidate gene reported in this study. 
SLC24A3 is a member of the solute carrier family and is located on 
the short arm of chromosome 20 (rs6081636, 20p13).  It is composed of 
562,256 nucleic bases and functions as a signaling molecule in the brain 
in sodium, potassium, and calcium exchange. Calcium and sodium 
exchangers are an integral component of intracellular homeostasis and 
the electrical conduction of neurons.  According to Yang, Lee, Yoo, Choi, 
and Jeung (2009), potassium-dependent sodium/calcium exchangers, 
such as SLC24A3, functionally are believed to exchange 1 intracellular 
calcium and 1 potassium ion for the transport of 4 extracellular sodium 
ions in humans and mice.  In mice SLC24A3 is regulated by the steroid 
hormones estrogen and progesterone (Yang, et al. 2009). 
Chromosome 20 or SLC24A3 has never been identified in previous 
linkage studies of stuttering. However, another member of the solute 
carrier family (SLC6A3) was identified in stuttering populations among 
the Han Chinese (Lan, Song, Pan, Zhuang, Wang, Ma, et al., 2009).  
SLC6A is located on the distal end of chromosome 5 (5p15.3) and not 
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proximally related to SLC24A3. 
 
Behavioral Genes 
 
Three significant SNPs (PLXNA4, EYA2 and FMN1) for stuttering 
risk have also been found in gene regions specifically implicated in 
addiction disorders. Addiction disorders are interrelated by common 
neurobiological pathways, including those that regulate reward, anxiety, 
stress response, and behavioral control (Goldman, Oroszi, & Ducci, 
2006). Addictions may include non-substance related behaviors such as 
gambling, playing video games and over-eating. It is hypothesized that 
certain repetitive behaviors might access the same neurobiological 
pathways that modulate impulsive behaviors, compulsive behaviors, 
mood and reward.  These same pathways are hypothesized to positively 
reinforce repetitive behaviors in an individual regardless of external 
judgment of benefit.  There is the presumption that for affected 
individuals a difficulty exists in their ability to execute a cessation of 
behaviors once they start; a notable comparison to stuttering behaviors. 
PLXNA4 (7q32.3) has been strongly associated with obesity by 
several genetic linkage and SNP association studies (see a review by 
Laramie, 2008).  Work by Laramie (2008) identified several SNPs located 
in the gene PLXNA4 that were consistently replicated in other obesity 
samples.  In general, the gene PLXNA4 repeatedly demonstrated a 
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significant increase in linkage disequilibrium in obese populations. 
Further evidence was sought for the influence of PLXNA4 in BMI (Body 
Mass Index, rated over 30 for obese individuals). A candidate gene 
analysis of PLXNA4 revealed a large deletion on chromosome 7 in the 
region of 7q32 in a subset of the study population. This deletion was 
examined for its association with obesity related phenotypes including 
BMI among others. Laramie (2008) reported evidence supporting the role 
of PLXNA4 not only in obesity and BMI, but also in type II diabetes. 
Individuals who were homozygous deletion carriers had a 58% reduced 
risk of developing type II diabetes. 
 Two SNPs (EYA2 and FMN1) were found in gene regions specifically 
implicated in alcoholism. EYA2 (rs6094607, 20q13.1), located on the long 
arm of human chromosome 20, spans about 293,984 nucleic bases and 
was first discovered in drosophila as the gene responsible for eye 
development (Bonini, Bui, Gray-Board, & Warrick, 1997).  Borsani, 
DeGrandi, Ballanio, Bulfone, Bernard, Banfi, Gattuso et al. (1999) 
identified this gene as a member of the eyes absent (EYA) family of 
proteins in humans. In humans, however, it reportedly works together 
with SIX1 and DACH2 in myogenesis (Abdelhak, Kalatzis, Heilig, 
Compain, Samson, Vincent, et al., 1997). Myogenesis is the formation of 
muscular tissue during embryonic development.  It is also known to 
interact with GNAZ and GNAI2 to prevent nuclear translocation and 
transcriptional activity during fetal development (Ho & Wong, 2001).   
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 Embry, Glick, Linder, and Casey (2004) performed a GWAS on 
individuals diagnosed with an alcohol use disorders. EYA2 was among 
172 other significant genes identified in a cohort of 367 affected sibling 
pairs. The study emphasized the magnitude of their findings was not in 
specific genes, but in genes that fit into functional categories, much like 
the current study.  
 EYA2 has also been found recently in association with Specific 
Language Impairment (Tomblin, Evans, & Cox, 2010, personal 
communication). These findings have not yet been published, and like 
stuttering, the involvement of EYA2 in speech and language disorders 
remains puzzling. Perhaps some pathogenesis of EYA2 in muscular 
tissue formation during fetal development contributes to the breakdown 
of muscular control and speech fluency in vivo.  
  FMN1 (rs12593365), located medially on the long arm of 
chromosome 15 (15q13.3) consisting of 293,741 nucleic bases, has no 
previous association with stuttering.  FMN1 was linked to alcoholism in 
2008, by Kitahara, Kawa, Katsuyama, Umemura, Ozaki, and Takayama, 
as being a top candidate gene for susceptibility to alcoholic chronic 
pancreatitis as investigated in a GWAS of 65 Japanese individuals 
diagnosed with the condition. This search revealed 10 candidate 
susceptibility regions and 5 candidate resistant regions throughout the 
investigated population genome. FMN1 was the top candidate pick for 
susceptibility to alcoholism in this population. Much of what FMN1 is 
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known to do is related to cellular adhesion and cellular structure.  FMN1 
contributes to the formation of adherens junctions (these are protein 
complexes that occur at cell-cell junctions in epithelial tissues) and is 
critically important in the polymerization of linear actin filaments that 
provide mechanical strength to cells (Zigmond, 2004). FMN1 interacts 
with alpha-catenin (a linking protein between cadherins (adhesion 
molecules that are calcium dependent) and actin-containing filaments) 
and may interact with tubulin (a globular protein that makes up 
mictrotubules) in fetal development (Zigmond, 2004). 
 
Cross-Involvement 
 
 A different categorical differentiation offers some striking 
similarities for other disorders associated with the same candidate genes 
investigated in this study. 
Table 5.2 Genetic overlap of candidate genes with other disorders 
Gene Overlap 
PLXNA4, ARNT2 Autism 
EYA2, FMN1 Alcoholism 
ADARB2, CTNNA3 Alzheimer’s disease 
 
 Genes implicated in additional disorders, such as alcoholism, were 
predicted, but the significance of overlap with autism and Alzheimer’s 
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disease was not anticipated and associations between the disorder of 
interest and these disorders remain unclear.  
 
Autism 
 
 Plexin A4 is a protein that works with semaphoring-3A in the brain 
to elicit inhibitory signals into cells and neurons (Laramie, 2008) PLXNA4  
(rs10231824) is located on the long arm of chromosome 7 (7q32.3), that 
is comprised of 874,817 nucleic bases. It was found in this association to 
be significant at p=2.94e-05.  This gene is located on a region of 
chromosome 7 implicated in a linkage study by Suresh et al. (2006). 
Another region on chromosome 7 reported by Riaz et al. (2005) nearby at 
7q36.3 was found to regulate PLXNA3, not PLXNA4 as identified in the 
GWAS, but a gene closely related and functionally in the same family of 
genes.  
PLXNA4 has recently been replicated in association with autism. 
Maestrini, Pagnamenta, Lamb, Bacchelli, Sykes, Sousa, et al. (2009) 
performed a high-density association analysis on chromosome 7 
(previously implicated in autism by linkage studies in The International 
Molecular Genetic Study of Autism Consortium) of 253 families with 
children diagnosed with autism. The investigators used two approaches, 
a case-control and a family-based analysis. One of the strongest signals 
in the family-based analysis was PLXNA4. 
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 Outside of autism, PLXNA4 and its co-receptor neuropilin-1 (a 
protein involved in axon guidance, cell survival, migration, and invasion) 
were found to be expressed in several vocal control areas in avian brains 
(Matsunaga & Okanoya, 2009).  Specifically this gene showed very strong 
association among two different families of vocal learners, the Bengalese 
finch (Lonchura striata domestica), a songbird, and the budgerigar 
(Melopsittacus undulatus), a parrot. These results suggest the possibility 
that the expression of PLXNA4 (in combination with semaphorin and 
neuropilin) is involved in the acquisition of vocal learning ability. 
ARNT2 (rs11072921) is the other candidate gene also implicated in 
autism. ARNT2 is made of 193,578 nucleic bases and is located on the 
long arm of chromosome 15 (15q24). It is a member of bHLH-PAS 
transcription factor family that is involved in the regulation of several 
important pathways, including toxin metabolism, neurogenesis, hypoxic 
response, biorhythms, and the formation of the trachea (Crews, 1998; 
Schmidt & Bradfield, 1996). This gene is specifically involved in the 
development of the neuroendocrine cells in the hypothalamus (Michaud, 
DeRossi, May, Holdener, & Fan, 2000). Chakrabarti, Dudbridge, Kent, 
Wheelwright, Hill-Cawthorne, Allison, et al. (2009) investigated 174 “high 
functioning” individuals diagnosed with autism, autistic traits, or 
Asperger syndrome. ARNT2 plays a role in brain development and may 
contribute to the abnormal neural connectivity that has been proposed to 
underlie autism spectrum disorders (Belmonte, Allen, Beckel-Mitchener, 
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Boulanger, Carper, & Webb, 2004). Two SNPs in the ARNT2 gene were 
found to be highly associated with the affected group. “These findings 
point to a key role played by these neurodevelopmental genes in the 
development of autistic traits” (Chakrabarti et al., 2009, p. 173). 
 ARNT2 has not been identified in any other genetic studies of 
stuttering. Riaz et al. (2005) identified a region (7q36.3) in a linkage 
study that regulates ARNT genes, however, a direct connection to ARNT2 
has not been studied at the molecular level. Assumptions as to the 
involvement of ARNT2 in stuttering remain limited to its potential role in 
neurogenesis or its contribution to the development of the neuro-
endocrine system that regulates stress response. 
 
Alzheimer’s disease 
 
 CTNNA3 and ADARB2 have both been independently associated 
with late-onset Alzheimer’s disease and are both located on chromosome 
10.  CTNNA3, known formally as catenin alpha 3, is located on the long 
arm of chromosome 10 (rs10996890, 10q21.3) and consists of 2,105,991 
nucleic bases.   It is thought to be involved in the formation of stretch-
resistant cell-cell adhesion complexes (Janssens, Goossens, Staes, 
Gilbert, van Hengel, Colpaert., et al., 2001).   
Thus far, CTNNA3 has not been previously implicated in stuttering 
risk, however, regions on chromosome 10 were identified by Shugart et 
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al. (2004).  Overlap of these regions with CTNNA3 are possible as location 
information was not provided in the referenced study. 
CTNNA3 is best known for its association with late-onset Alzheimer’s 
disease (Bertram, Blacker, Mullin, Keeney, Jones, Basu, et al., 2000; 
Ertekin-Taner, Graff-Radford, Younkin, Eckman, Baker, Adamson, 
Ronald, et al., 2000; Myers, Holmans, Marshall, Kwon, Meyer, Ramic, et 
al., 2000). Myers et al. (2000) reported that CTNNA3 is an uncommonly 
large gene spanning over 1.7Mb and covering several SNP regions. Within 
CTNNA3 are two smaller significant gene regions that have also been 
implicated in Alzheimer’s disease. One of these genes is an encoding 
insulin degrading enzyme (IDE) and has been shown to be independently 
significant from CTNNA3 in Alzheimer’s disease association studies 
(Prince, Feuk, Gu, Johansson, Gatz, Blennow, et al., 2003). Insulin and 
insulin-like signaling pathways have been investigated in animal models. 
Components of these pathways were found to be involved not in 
Alzheimer’s disease suceptibility, but in the regulation of lifespan (Hong, 
Reynolds, Gatz, Johansson, Palmer, Gu, et al., 2008).  Until recently, the 
relevance of those findings in human insulin pathways has remained 
obscure. In 2008, Hong and colleagues found evidence that IDE, the 
insulin degrading enzyme (the gene found within the gene region of 
CTNNA3) may be influencing human life expectancy. Replications of this 
study have shown changes in IDE to be related to advancing age in men. 
Thus suggesting that insulin levels are only associated with IDE in males 
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(Hong, et al., 2008).  
IDE is one of the central regulators of insulin metabolism, but also 
plays and integral role in the degrading of a variety of sugar proteins 
such as IGF2 and β-amyloid (Hong et al., 2008). Not only has this gene 
been associated with Alzheimer’s disease and life expectancy, but also 
with type II diabetes (Karamohamed, Demissie, Volchak, Liu, Heard-
Costa, Liu, et al., 2003). This gene, like PCSK5 (discussed later), plays an 
integral role in processing sugars in the brain. The role of sugar 
transport and stuttering have yet to be investigated at the molecular 
level, but remains an area of intrigue.  
Another expression of CTNNA3 in the brain functions to bind itself 
to β-catenin and acts as a negative regulator of the Wnt-signalling 
cascade (Busby, Goossens, Nowotny, Hamilton, Smemo, Harold, et al., 
2004). The Wnt-signaling cascade is required for several crucial steps 
during early embryogenesis, and its activity is modulated by various 
agonists and antagonists to provide spatiotemporal-specific signaling 
(Creyghton, Roel, Eichhorn, Vredeveld, Destree, & Bernards, 2006). 
ADARB2 is located at the very end of the short arm on 
chromosome 10 (10p15.3) and consists of 561,598 nucleic bases.  This 
gene encodes a member of the double-stranded RNA adenosine 
deaminase family of RNA-editing enzymes and is thought to play a 
regulatory role in RNA editing (Mittaz, Antonarakis, Huguchi, & Scott, 
1997). ADARB2 was found in association with late-onset Alzheimer’s 
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disease in a population of 422 affected cases from Washington University 
Alzheimer’s Disease Research Center patient registry, but was not 
significantly replicated in the same study investigating the association of 
multiple candidate gene regions in 368 cases from the UK and from 217 
additional cases collected through the University of California–San Diego 
(Grupe, Li, Rowland, Nowotny, Hinrichs, Smemo, et al., 2006).   
The functional contribution of ADARB2 to Alzheimer’s disease has 
not yet been investigated, however, ADARB2 has been found to edit the 
mRNA of GluR2 (L-glutamate receptor) in normally functioning adults 
(Kawahara, Ito, Sun, Kanazawa, & Kwak, 2003).  L-glutamate is the 
primary excitatory neurotransmitter in the central nervous system 
(Meldrum, 2000). Glutamate neurotransmission is involved in most 
aspects of normal brain function and is disrupted in many 
neuropathologic conditions such as Huntington's disease, spino-
cerebellar degeneration syndromes, and motor neuron diseases (Bittigau 
& Ikonomidou, 1997). GluR2, a glutamate receptor, is critically regulated 
by ADARB2 in the human brain. Kawahara et al. (2003) found that an 
abundance of ADARB2 inhibited the amount of GluR2 present in white 
matter. This discovery may lead to an understanding of deficient 
glutamate transmission as the mechanism underlying neurological 
diseases and eventual neuron death. 
Differences in white matter have been found in the brains of people 
who stutter. Chang, Erickson, Ambrose, Hasegawa-Johnson, and Ludlow 
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(2008) found a decrease in white matter tracts underlying the oral facial 
motor regions of the left hemisphere in children who persistently stutter. 
A study investigating white matter tracts in adults found right-
hemispheric increases in white matter volume in several brain regions 
critical to speech and language production and face and mouth control. 
These adults also lacked the normal left–right asymmetry in white matter 
volume in the auditory cortex (Jancke, Hanggi, & Steinmetz, 2004). In a 
study by Choo, Kraft, Loucks, Ambrose, Olivero, Sharma, et al. (2010, in 
review) the posterior region of the corpus collosum (a white matter tract 
connecting the right and left hemispheres of the brain) was found to be 
significantly thinner in adults who persistently stutter than controls. 
Considering that ADARB2 and GluR2 are significantly involved in white 
matter and motor neuron pathology, it is interesting to note that motor 
stability (Kleinow & Smith, 2000)and motor-muscle movement initiation 
(Salmelin, Schnitzler, Schmitz & Freund, 2000) is observed to be 
aberrant in people who stutter leading to a potentially interesting 
functional connection between ADARB2 and persistent developmental 
stuttering.  
 
Study Limitations: 
 
This discussion remains speculative at this stage. Ninety-seven 
SNPs were statistically significant for association with stuttering in this 
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study. While this data suggests that there is an excess of associated 
SNPs when compared to random expectations, there is no strong 
evidence implicating a specific marker, SNP, or gene among these. The 
lack of strong statistical support for an individual marker in this 
experiment is not unusual in the context of recent reports of GWAS 
experiments looking at other genetically complex diseases.  Thus ten of 
the top SNPs containing known genes were analytically investigated as 
candidate regions for stuttering risk. 
 Significant limitations of this study result from a fairly small 
sample population. While most studies investigating the genetics of 
stuttering have historically been very small, typical discovery phase 
GWAS studies require a sample size of approximately 400 cases and 
controls to draw strong statistical assumptions regarding association 
with disease risk (Pearson & Monolio, 2008). 
Despite this limitation, this study has succeeded in demonstrating 
association in the set of candidate genes chosen, significantly higher 
than would be expected from a random selection of genes. This is 
important because this study was designed to be an exploratory whole-
genome scan, rather than a testing multiple strong candidates previously 
identified in other studies. Each candidate SNP had fairly strong p-values 
reflecting a strong association with stuttering in this population. It is 
therefore reasonable to report these genes with genome-wide 
significance.  In this study, only 10 candidate genes were discussed in 
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detail, this was due to the lack of functional information available for 
most SNP regions.  Ninety-seven SNPs in this study reached nominal 
significance, with only 22 containing known genes.  It is suggested that 
all such SNPs/genes are plausible targets for further replication whether 
functional information is currently available.  
 
Conclusions: 
 
In this study, 10 nominally significant candidate genes were 
assessed for functional significance to persistent developmental 
stuttering, some of which are also associated with autism, alcoholism, 
and Alzheimer’s disease. These 10 genes fall into the three functional 
categories related to neural development, neural function, and behavior, 
providing some support for the three purposed theories of stuttering 
transmission and genetic influence.  
 
Future Directions 
 
These initial associations are being followed up with fine-mapping 
of functional and causal variants, which may reveal genetic mechanisms 
with more precision. There is a strong need to conduct a large-scale 
replication study on this set of significant SNPs in a population sample 
with persistent developmental stuttering.  Future studies will test these 
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genes in expression studies, as well as in individuals of diverse ancestry 
and in those who have naturally recovered to establish which 
combination of common SNPs (which individually are non-pathological) 
are common to the etiology of anyone affected with the disorder of 
stuttering. 
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